Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,121 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

NCT01702831

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada
  • Vancouver General Hospital, Centennial Pavilion, 6th Floor Vancouver, British Columbia, Canada
  • Saint John Regional Hospital, 5DN Research Department, 400 University Ave Saint John, New Brunswick, Canada
  • Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada
View Trial Details
Completed

Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

NCT01868451

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View Trial Details
Completed

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

NCT04502030

Conditions
Agammaglobulinemia, Blood Protein Disorders, Chronic Disease, +18 more
Locations
  • Octapharma Research Site St. Petersburg, Florida, United States
  • Octapharma Research Site Columbus, Georgia, United States
  • Octapharma Research Site Macon, Georgia, United States
  • Octapharma Research Site New Orleans, Louisiana, United States
View all 84 locations
View Trial Details
Completed

CAR-T for R/R B-NHL

NCT03196830

Conditions
CAR - T CD19/CD20/CD22/CD30, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • the First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
View Trial Details
Completed

A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis

NCT05020652

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Guangdong Provincial Peoples Hospital Guangzhou, Guangdong, China
  • West China School of Medicine / West China Hospital, Sichuan University Chengdu, Sichuan, China
  • Institute of Hematology & Blood Diseases Hostpital, Chinese Academy of medical sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
View Trial Details
Completed

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

NCT02883049

Conditions
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like, Burkitt Lymphoma, +18 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
View all 239 locations
View Trial Details

Related conditions